Skip to content

Clinical trials

Head and Neck Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Head and Neck Neoplasms Country / region: Italy Clear all

133 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20032
20041
20052
20062
20081
20092
20102
20112
20122
20132
20142
201511
20165
201710
20182
20198
20207
202110
20229
202314
202411
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting30
Unknown status17
Active, not recruiting16
Terminated14
Not yet recruiting5
Suspended1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Institute of Oncology8
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano8
European Organisation for Research and Treatment of Cancer - EORTC7
Fondazione Policlinico Universitario Agostino Gemelli IRCCS7
Eli Lilly and Company5
GlaxoSmithKline5
Hoffmann-La Roche5
AstraZeneca4
Novartis Pharmaceuticals4
CNAO National Center of Oncological Hadrontherapy3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Head and Neck Neoplasms133
Squamous Cell Carcinoma of Head and Neck33
Breast Neoplasms18
Neoplasms18
Lung Neoplasms17
Carcinoma, Non-Small-Cell Lung15
Colorectal Neoplasms10
Melanoma10
Ovarian Neoplasms8
Colonic Neoplasms7

Trials

Showing 26 to 50 of 133. Each trial links to its page on Pharma Observatory.

33 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.